Organon & Co. (OGN) is a publicly traded Healthcare sector company. As of May 21, 2026, OGN trades at $13.40 with a market cap of $3.52B and a P/E ratio of 14.29. OGN moved +0.34% today. Year to date, OGN is +80.91%; over the trailing twelve months it is +53.65%. Its 52-week range spans $5.69 to $19.41. Analyst consensus is neutral with an average price target of $11.25. Rallies surfaces OGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Recent OGN insider activity includes Holzbaur Lynette sold 26.45K, Holzbaur Lynette bought 26.45K, and COX CARRIE SMITH bought 65.40K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
| Metric | Value |
|---|---|
| Price | $13.40 |
| Market Cap | $3.52B |
| P/E Ratio | 14.29 |
| EPS | $0.94 |
| Dividend Yield | 0.02% |
| 52-Week High | $19.41 |
| 52-Week Low | $5.69 |
| Volume | 2 |
| Avg Volume | 0 |
| Revenue (TTM) | $6.16B |
| Net Income | $246.00M |
| Gross Margin | 52.81% |
5 analysts cover OGN: 0 strong buy, 0 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $11.25.